| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DVA - DaVita HealthCare Partners Inc | SELL | -80 @ USD 110.1 | USD -8,808 | The ETF sold 80 shares of DVA on 2026-01-12. The shares were previously bought for an average price of USD 139.114. The DaVita HealthCare Partners Inc shares were sold for -20.9% lower than average price of previous purchases. This resulted in an overall loss of USD 2,321 The average price that the ETF previously sold DVA share for is USD 142.366 which is higher than the selling price of USD 110.1 on 2026-01-12. |
| HSIC - Henry Schein Inc | SELL | -232 @ USD 76.13 | USD -17,662 | The ETF sold 232 shares of HSIC on 2026-01-12. The shares were previously bought for an average price of USD 71.5124. The Henry Schein Inc shares were sold for 6.5% higher than average price of previous purchases. This sale made a profit of USD 1,071 The average price that the ETF previously sold HSIC share for is USD 69.8135 so the ETF has sold 232 shares on 2026-01-12 at a higher price than the previous selling average. |
| MOH - MOH | SELL | -112 @ USD 181.82 | USD -20,364 | The ETF sold 112 shares of MOH on 2026-01-12. The shares were previously bought for an average price of USD 229.275. The MOH shares were sold for -20.7% lower than average price of previous purchases. This resulted in an overall loss of USD 5,315 The average price that the ETF previously sold MOH share for is USD 266.96 which is higher than the selling price of USD 181.82 on 2026-01-12. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -112 @ USD 181.82 | USD -20,364 | The ETF sold 112 shares of MOH on 2026-01-12. The shares were previously bought for an average price of USD 229.275. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -20.7% lower than average price of previous purchases. This resulted in an overall loss of USD 5,315 The average price that the ETF previously sold MOH share for is USD 266.96 which is higher than the selling price of USD 181.82 on 2026-01-12. |
| BAX - Baxter International Inc | SELL | -1,148 @ USD 20.15 | USD -23,132 | The ETF sold 1148 shares of BAX on 2026-01-12. The shares were previously bought for an average price of USD 26.7735. The Baxter International Inc shares were sold for -24.7% lower than average price of previous purchases. This resulted in an overall loss of USD 7,604 The average price that the ETF previously sold BAX share for is USD 30.1385 which is higher than the selling price of USD 20.15 on 2026-01-12. |
| TECH - Bio-Techne Corp | SELL | -348 @ USD 66.56 | USD -23,163 | The ETF sold 348 shares of TECH on 2026-01-12. The shares were previously bought for an average price of USD 60.5168. The Bio-Techne Corp shares were sold for 10.0% higher than average price of previous purchases. This sale made a profit of USD 2,103 The average price that the ETF previously sold TECH share for is USD 65.7027 so the ETF has sold 348 shares on 2026-01-12 at a higher price than the previous selling average. |
| CRL - Creightons Plc | SELL | -108 @ USD 218.82 | USD -23,633 | The ETF sold 108 shares of CRL on 2026-01-12. The shares were previously bought for an average price of USD 170.33. The Creightons Plc shares were sold for 28.5% higher than average price of previous purchases. This sale made a profit of USD 5,237 The average price that the ETF previously sold CRL share for is USD 174.964 so the ETF has sold 108 shares on 2026-01-12 at a higher price than the previous selling average. |
| UHS - Universal Health Services Inc | SELL | -120 @ USD 205.96 | USD -24,715 | The ETF sold 120 shares of UHS on 2026-01-12. The shares were previously bought for an average price of USD 198.162. The Universal Health Services Inc shares were sold for 3.9% higher than average price of previous purchases. This sale made a profit of USD 936 The average price that the ETF previously sold UHS share for is USD 198.045 so the ETF has sold 120 shares on 2026-01-12 at a higher price than the previous selling average. |
| ALGN - Align Technology Inc | SELL | -148 @ USD 172 | USD -25,456 | The ETF sold 148 shares of ALGN on 2026-01-12. The shares were previously bought for an average price of USD 166.611. The Align Technology Inc shares were sold for 3.2% higher than average price of previous purchases. This sale made a profit of USD 798 The average price that the ETF previously sold ALGN share for is USD 198.054 which is higher than the selling price of USD 172 on 2026-01-12. |
| RVTY - Revvity Inc. | SELL | -248 @ USD 103.89 | USD -25,765 | The ETF sold 248 shares of RVTY on 2026-01-12. The shares were previously bought for an average price of USD 102.623. The Revvity Inc. shares were sold for 1.2% higher than average price of previous purchases. This sale made a profit of USD 314 The average price that the ETF previously sold RVTY share for is USD 106.381 which is higher than the selling price of USD 103.89 on 2026-01-12. |
| MRNA - Moderna Inc | SELL | -768 @ USD 33.84 | USD -25,989 | The ETF sold 768 shares of MRNA on 2026-01-12. The shares were previously bought for an average price of USD 30.2464. The Moderna Inc shares were sold for 11.9% higher than average price of previous purchases. This sale made a profit of USD 2,760 The average price that the ETF previously sold MRNA share for is USD 36.9385 which is higher than the selling price of USD 33.84 on 2026-01-12. |
| SOLV - Solventum Corp. | SELL | -324 @ USD 85.69 | USD -27,764 | The ETF sold 324 shares of SOLV on 2026-01-12. The shares were previously bought for an average price of USD 74.3798. The Solventum Corp. shares were sold for 15.2% higher than average price of previous purchases. This sale made a profit of USD 3,665 The average price that the ETF previously sold SOLV share for is USD 72.174 so the ETF has sold 324 shares on 2026-01-12 at a higher price than the previous selling average. |
| VTRS - Viatris Inc | SELL | -2,564 @ USD 12.68 | USD -32,512 | The ETF sold 2564 shares of VTRS on 2026-01-12. The shares were previously bought for an average price of USD 10.4743. The Viatris Inc shares were sold for 21.1% higher than average price of previous purchases. This sale made a profit of USD 5,655 The average price that the ETF previously sold VTRS share for is USD 11.139 so the ETF has sold 2564 shares on 2026-01-12 at a higher price than the previous selling average. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -440 @ USD 83.23 | USD -36,621 | The ETF sold 440 shares of COO on 2026-01-12. The shares were previously bought for an average price of USD 80.8312. The The Cooper Companies, Inc. Common Stock shares were sold for 3.0% higher than average price of previous purchases. This sale made a profit of USD 1,055 The average price that the ETF previously sold COO share for is USD 88.447 which is higher than the selling price of USD 83.23 on 2026-01-12. |
| HOLX - Hologic Inc | SELL | -492 @ USD 74.86 | USD -36,831 | The ETF sold 492 shares of HOLX on 2026-01-12. The shares were previously bought for an average price of USD 69.0376. The Hologic Inc shares were sold for 8.4% higher than average price of previous purchases. This sale made a profit of USD 2,865 The average price that the ETF previously sold HOLX share for is USD 71.0281 so the ETF has sold 492 shares on 2026-01-12 at a higher price than the previous selling average. |
| INCY - Incyte Corporation | SELL | -364 @ USD 106.33 | USD -38,704 | The ETF sold 364 shares of INCY on 2026-01-12. The shares were previously bought for an average price of USD 81.7058. The Incyte Corporation shares were sold for 30.1% higher than average price of previous purchases. This sale made a profit of USD 8,963 The average price that the ETF previously sold INCY share for is USD 75.6619 so the ETF has sold 364 shares on 2026-01-12 at a higher price than the previous selling average. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -440 @ USD 91.45 | USD -40,238 | The ETF sold 440 shares of ZBH on 2026-01-12. The shares were previously bought for an average price of USD 100.793. The Zimmer Biomet Holdings Inc shares were sold for -9.3% lower than average price of previous purchases. This resulted in an overall loss of USD 4,111 The average price that the ETF previously sold ZBH share for is USD 103.367 which is higher than the selling price of USD 91.45 on 2026-01-12. |
| PODD - Insulet Corporation | SELL | -156 @ USD 278.55 | USD -43,454 | The ETF sold 156 shares of PODD on 2026-01-12. The shares were previously bought for an average price of USD 295.57. The Insulet Corporation shares were sold for -5.8% lower than average price of previous purchases. This resulted in an overall loss of USD 2,655 The average price that the ETF previously sold PODD share for is USD 277.623 so the ETF has sold 156 shares on 2026-01-12 at a higher price than the previous selling average. |
| DGX - Quest Diagnostics Incorporated | SELL | -248 @ USD 175.94 | USD -43,633 | The ETF sold 248 shares of DGX on 2026-01-12. The shares were previously bought for an average price of USD 175.663. The Quest Diagnostics Incorporated shares were sold for 0.2% higher than average price of previous purchases. This sale made a profit of USD 69 The average price that the ETF previously sold DGX share for is USD 165.911 so the ETF has sold 248 shares on 2026-01-12 at a higher price than the previous selling average. |
| WST - West Pharmaceutical Services Inc | SELL | -160 @ USD 272.91 | USD -43,666 | The ETF sold 160 shares of WST on 2026-01-12. The shares were previously bought for an average price of USD 259.894. The West Pharmaceutical Services Inc shares were sold for 5.0% higher than average price of previous purchases. This sale made a profit of USD 2,083 The average price that the ETF previously sold WST share for is USD 284.953 which is higher than the selling price of USD 272.91 on 2026-01-12. |
| LH - Laboratory Corporation of America Holdings | SELL | -184 @ USD 250.39 | USD -46,072 | The ETF sold 184 shares of LH on 2026-01-12. The shares were previously bought for an average price of USD 257.237. The Laboratory Corporation of America Holdings shares were sold for -2.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,260 The average price that the ETF previously sold LH share for is USD 243.761 so the ETF has sold 184 shares on 2026-01-12 at a higher price than the previous selling average. |
| CNC - Concurrent Technologies Plc | SELL | -1,032 @ USD 46.39 | USD -47,874 | The ETF sold 1032 shares of CNC on 2026-01-12. The shares were previously bought for an average price of USD 46.2006. The Concurrent Technologies Plc shares were sold for 0.4% higher than average price of previous purchases. This sale made a profit of USD 195 The average price that the ETF previously sold CNC share for is USD 52.3215 which is higher than the selling price of USD 46.39 on 2026-01-12. |
| WAT - Waters Corporation | SELL | -132 @ USD 393.68 | USD -51,966 | The ETF sold 132 shares of WAT on 2026-01-12. The shares were previously bought for an average price of USD 354.679. The Waters Corporation shares were sold for 11.0% higher than average price of previous purchases. This sale made a profit of USD 5,148 The average price that the ETF previously sold WAT share for is USD 365.385 so the ETF has sold 132 shares on 2026-01-12 at a higher price than the previous selling average. |
| WAT - MULETFWATIMETFP | SELL | -132 @ USD 393.68 | USD -51,966 | The ETF sold 132 shares of WAT on 2026-01-12. The shares were previously bought for an average price of USD 354.679. The MULETFWATIMETFP shares were sold for 11.0% higher than average price of previous purchases. This sale made a profit of USD 5,148 The average price that the ETF previously sold WAT share for is USD 365.385 so the ETF has sold 132 shares on 2026-01-12 at a higher price than the previous selling average. |
| STE - STERIS plc | SELL | -220 @ USD 260.77 | USD -57,369 | The ETF sold 220 shares of STE on 2026-01-12. The shares were previously bought for an average price of USD 238.681. The STERIS plc shares were sold for 9.3% higher than average price of previous purchases. This sale made a profit of USD 4,860 The average price that the ETF previously sold STE share for is USD 224.686 so the ETF has sold 220 shares on 2026-01-12 at a higher price than the previous selling average. |
| BIIB - Biogen Inc | SELL | -320 @ USD 185.63 | USD -59,402 | The ETF sold 320 shares of BIIB on 2026-01-12. The shares were previously bought for an average price of USD 149.08. The Biogen Inc shares were sold for 24.5% higher than average price of previous purchases. This sale made a profit of USD 11,696 The average price that the ETF previously sold BIIB share for is USD 153.446 so the ETF has sold 320 shares on 2026-01-12 at a higher price than the previous selling average. |
| DXCM - DexCom Inc | SELL | -868 @ USD 70.98 | USD -61,611 | The ETF sold 868 shares of DXCM on 2026-01-12. The shares were previously bought for an average price of USD 73.69. The DexCom Inc shares were sold for -3.7% lower than average price of previous purchases. This resulted in an overall loss of USD 2,352 The average price that the ETF previously sold DXCM share for is USD 75.9754 which is higher than the selling price of USD 70.98 on 2026-01-12. |
| MTD - Mettler-Toledo International Inc | SELL | -44 @ USD 1491.99 | USD -65,648 | The ETF sold 44 shares of MTD on 2026-01-12. The shares were previously bought for an average price of USD 1306.57. The Mettler-Toledo International Inc shares were sold for 14.2% higher than average price of previous purchases. This sale made a profit of USD 8,158 The average price that the ETF previously sold MTD share for is USD 1253.47 so the ETF has sold 44 shares on 2026-01-12 at a higher price than the previous selling average. |
| MTD - AMUNDI EUR GOV 710 | SELL | -44 @ USD 1491.99 | USD -65,648 | The ETF sold 44 shares of MTD on 2026-01-12. The shares were previously bought for an average price of USD 1306.57. The AMUNDI EUR GOV 710 shares were sold for 14.2% higher than average price of previous purchases. This sale made a profit of USD 8,158 The average price that the ETF previously sold MTD share for is USD 1253.47 so the ETF has sold 44 shares on 2026-01-12 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -264 @ USD 276.59 | USD -73,020 | The ETF sold 264 shares of HUM on 2026-01-12. The shares were previously bought for an average price of USD 265.47. The Hummingbird Resources PLC shares were sold for 4.2% higher than average price of previous purchases. This sale made a profit of USD 2,936 The average price that the ETF previously sold HUM share for is USD 266.987 so the ETF has sold 264 shares on 2026-01-12 at a higher price than the previous selling average. |
| HUM - Humana Inc | SELL | -264 @ USD 276.59 | USD -73,020 | The ETF sold 264 shares of HUM on 2026-01-12. The shares were previously bought for an average price of USD 265.47. The Humana Inc shares were sold for 4.2% higher than average price of previous purchases. This sale made a profit of USD 2,936 The average price that the ETF previously sold HUM share for is USD 266.987 so the ETF has sold 264 shares on 2026-01-12 at a higher price than the previous selling average. |
| RMD - ResMed Inc | SELL | -324 @ USD 257.84 | USD -83,540 | The ETF sold 324 shares of RMD on 2026-01-12. The shares were previously bought for an average price of USD 251.463. The ResMed Inc shares were sold for 2.5% higher than average price of previous purchases. This sale made a profit of USD 2,066 The average price that the ETF previously sold RMD share for is USD 244.698 so the ETF has sold 324 shares on 2026-01-12 at a higher price than the previous selling average. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -1,004 @ USD 86.9 | USD -87,248 | The ETF sold 1004 shares of GEHC on 2026-01-12. The shares were previously bought for an average price of USD 79.5851. The GE HealthCare Technologies Inc. shares were sold for 9.2% higher than average price of previous purchases. This sale made a profit of USD 7,344 The average price that the ETF previously sold GEHC share for is USD 79.2355 so the ETF has sold 1004 shares on 2026-01-12 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -376 @ USD 240.86 | USD -90,563 | The ETF sold 376 shares of IQV on 2026-01-12. The shares were previously bought for an average price of USD 198.014. The IQVIA Holdings Inc shares were sold for 21.6% higher than average price of previous purchases. This sale made a profit of USD 16,110 The average price that the ETF previously sold IQV share for is USD 191.754 so the ETF has sold 376 shares on 2026-01-12 at a higher price than the previous selling average. |
| A - Agilent Technologies Inc | SELL | -624 @ USD 147.99 | USD -92,346 | The ETF sold 624 shares of A on 2026-01-12. The shares were previously bought for an average price of USD 131.651. The Agilent Technologies Inc shares were sold for 12.4% higher than average price of previous purchases. This sale made a profit of USD 10,196 The average price that the ETF previously sold A share for is USD 131.784 so the ETF has sold 624 shares on 2026-01-12 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -520 @ USD 202.52 | USD -105,310 | The ETF sold 520 shares of CAH on 2026-01-12. The shares were previously bought for an average price of USD 156.116. The Cardinal Health Inc shares were sold for 29.7% higher than average price of previous purchases. This sale made a profit of USD 24,130 The average price that the ETF previously sold CAH share for is USD 140.201 so the ETF has sold 520 shares on 2026-01-12 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -1,284 @ USD 83.01 | USD -106,585 | The ETF sold 1284 shares of EW on 2026-01-12. The shares were previously bought for an average price of USD 76.199. The Edwards Lifesciences Corp shares were sold for 8.9% higher than average price of previous purchases. This sale made a profit of USD 8,745 The average price that the ETF previously sold EW share for is USD 73.3383 so the ETF has sold 1284 shares on 2026-01-12 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -976 @ USD 125.32 | USD -122,312 | The ETF sold 976 shares of ZTS on 2026-01-12. The shares were previously bought for an average price of USD 149.91. The Zoetis Inc shares were sold for -16.4% lower than average price of previous purchases. This resulted in an overall loss of USD 24,000 The average price that the ETF previously sold ZTS share for is USD 163.272 which is higher than the selling price of USD 125.32 on 2026-01-12. |
| IDXX - IDEXX Laboratories Inc | SELL | -176 @ USD 724.76 | USD -127,558 | The ETF sold 176 shares of IDXX on 2026-01-12. The shares were previously bought for an average price of USD 577.553. The IDEXX Laboratories Inc shares were sold for 25.5% higher than average price of previous purchases. This sale made a profit of USD 25,908 The average price that the ETF previously sold IDXX share for is USD 486.445 so the ETF has sold 176 shares on 2026-01-12 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -632 @ USD 202.74 | USD -128,132 | The ETF sold 632 shares of BDX on 2026-01-12. The shares were previously bought for an average price of USD 204.343. The Becton Dickinson and Company shares were sold for -0.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,013 The average price that the ETF previously sold BDX share for is USD 208.9 which is higher than the selling price of USD 202.74 on 2026-01-12. |
| COR - Cencora Inc. | SELL | -428 @ USD 342.16 | USD -146,444 | The ETF sold 428 shares of COR on 2026-01-12. The shares were previously bought for an average price of USD 303.841. The Cencora Inc. shares were sold for 12.6% higher than average price of previous purchases. This sale made a profit of USD 16,401 The average price that the ETF previously sold COR share for is USD 271.016 so the ETF has sold 428 shares on 2026-01-12 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -592 @ USD 276.02 | USD -163,404 | The ETF sold 592 shares of CI on 2026-01-12. The shares were previously bought for an average price of USD 296.954. The Cigna Corp shares were sold for -7.0% lower than average price of previous purchases. This resulted in an overall loss of USD 12,393 The average price that the ETF previously sold CI share for is USD 307.721 which is higher than the selling price of USD 276.02 on 2026-01-12. |
| HCA - HCA Holdings Inc | SELL | -352 @ USD 474.32 | USD -166,961 | The ETF sold 352 shares of HCA on 2026-01-12. The shares were previously bought for an average price of USD 395.487. The HCA Holdings Inc shares were sold for 19.9% higher than average price of previous purchases. This sale made a profit of USD 27,749 The average price that the ETF previously sold HCA share for is USD 367.365 so the ETF has sold 352 shares on 2026-01-12 at a higher price than the previous selling average. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -224 @ USD 768 | USD -172,032 | The ETF sold 224 shares of REGN on 2026-01-12. The shares were previously bought for an average price of USD 665.405. The Regeneron Pharmaceuticals Inc shares were sold for 15.4% higher than average price of previous purchases. This sale made a profit of USD 22,981 The average price that the ETF previously sold REGN share for is USD 691.744 so the ETF has sold 224 shares on 2026-01-12 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -492 @ USD 374.97 | USD -184,485 | The ETF sold 492 shares of ELV on 2026-01-12. The shares were previously bought for an average price of USD 365.261. The Elevance Health Inc shares were sold for 2.7% higher than average price of previous purchases. This sale made a profit of USD 4,777 The average price that the ETF previously sold ELV share for is USD 383.991 which is higher than the selling price of USD 374.97 on 2026-01-12. |
| ELV - Elevance Health Inc | SELL | -492 @ USD 374.97 | USD -184,485 | The ETF sold 492 shares of ELV on 2026-01-12. The shares were previously bought for an average price of USD 365.261. The Elevance Health Inc shares were sold for 2.7% higher than average price of previous purchases. This sale made a profit of USD 4,777 The average price that the ETF previously sold ELV share for is USD 383.991 which is higher than the selling price of USD 374.97 on 2026-01-12. |
| MCK - McKesson Corporation | SELL | -272 @ USD 825.62 | USD -224,569 | The ETF sold 272 shares of MCK on 2026-01-12. The shares were previously bought for an average price of USD 715.317. The McKesson Corporation shares were sold for 15.4% higher than average price of previous purchases. This sale made a profit of USD 30,002 The average price that the ETF previously sold MCK share for is USD 654.028 so the ETF has sold 272 shares on 2026-01-12 at a higher price than the previous selling average. |
| CVS - CVS Health Corp | SELL | -2,804 @ USD 80.36 | USD -225,329 | The ETF sold 2804 shares of CVS on 2026-01-12. The shares were previously bought for an average price of USD 70.508. The CVS Health Corp shares were sold for 14.0% higher than average price of previous purchases. This sale made a profit of USD 27,625 The average price that the ETF previously sold CVS share for is USD 60.4213 so the ETF has sold 2804 shares on 2026-01-12 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -4,500 @ USD 55.77 | USD -250,965 | The ETF sold 4500 shares of BMY on 2026-01-12. The shares were previously bought for an average price of USD 51.9331. The Bloomsbury Publishing Plc shares were sold for 7.4% higher than average price of previous purchases. This sale made a profit of USD 17,266 The average price that the ETF previously sold BMY share for is USD 53.4194 so the ETF has sold 4500 shares on 2026-01-12 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -560 @ USD 460.59 | USD -257,930 | The ETF sold 560 shares of VRTX on 2026-01-12. The shares were previously bought for an average price of USD 443.119. The Vertex Pharmaceuticals Inc shares were sold for 3.9% higher than average price of previous purchases. This sale made a profit of USD 9,784 The average price that the ETF previously sold VRTX share for is USD 457.408 so the ETF has sold 560 shares on 2026-01-12 at a higher price than the previous selling average. |
| MDT - Medtronic PLC | SELL | -2,832 @ USD 96.95 | USD -274,562 | The ETF sold 2832 shares of MDT on 2026-01-12. The shares were previously bought for an average price of USD 92.5007. The Medtronic PLC shares were sold for 4.8% higher than average price of previous purchases. This sale made a profit of USD 12,600 The average price that the ETF previously sold MDT share for is USD 87.5685 so the ETF has sold 2832 shares on 2026-01-12 at a higher price than the previous selling average. |
| SYK - Stryker Corporation | SELL | -760 @ USD 361.37 | USD -274,641 | The ETF sold 760 shares of SYK on 2026-01-12. The shares were previously bought for an average price of USD 373.017. The Stryker Corporation shares were sold for -3.1% lower than average price of previous purchases. This resulted in an overall loss of USD 8,852 The average price that the ETF previously sold SYK share for is USD 376.285 which is higher than the selling price of USD 361.37 on 2026-01-12. |
| BSX - Boston Scientific Corporation | SELL | -3,276 @ USD 95.72 | USD -313,579 | The ETF sold 3276 shares of BSX on 2026-01-12. The shares were previously bought for an average price of USD 99.042. The Boston Scientific Corporation shares were sold for -3.4% lower than average price of previous purchases. This resulted in an overall loss of USD 10,883 The average price that the ETF previously sold BSX share for is USD 94.3507 so the ETF has sold 3276 shares on 2026-01-12 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -3,276 @ USD 95.72 | USD -313,579 | The ETF sold 3276 shares of BSX on 2026-01-12. The shares were previously bought for an average price of USD 99.042. The MULSTRXSSXIMETFP shares were sold for -3.4% lower than average price of previous purchases. This resulted in an overall loss of USD 10,883 The average price that the ETF previously sold BSX share for is USD 94.3507 so the ETF has sold 3276 shares on 2026-01-12 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -12,560 @ USD 25.27 | USD -317,391 | The ETF sold 12560 shares of PFE on 2026-01-12. The shares were previously bought for an average price of USD 25.3765. The Pfizer Inc shares were sold for -0.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,338 The average price that the ETF previously sold PFE share for is USD 25.5293 which is higher than the selling price of USD 25.27 on 2026-01-12. |
| DHR - Danaher Corporation | SELL | -1,388 @ USD 239 | USD -331,732 | The ETF sold 1388 shares of DHR on 2026-01-12. The shares were previously bought for an average price of USD 215.054. The Danaher Corporation shares were sold for 11.1% higher than average price of previous purchases. This sale made a profit of USD 33,237 The average price that the ETF previously sold DHR share for is USD 223.4 so the ETF has sold 1388 shares on 2026-01-12 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -1,388 @ USD 239 | USD -331,732 | The ETF sold 1388 shares of DHR on 2026-01-12. The shares were previously bought for an average price of USD 215.054. The Danaher Corporation shares were sold for 11.1% higher than average price of previous purchases. This sale made a profit of USD 33,237 The average price that the ETF previously sold DHR share for is USD 223.4 so the ETF has sold 1388 shares on 2026-01-12 at a higher price than the previous selling average. |
| GILD - Guild Esports Plc | SELL | -2,740 @ USD 122.6 | USD -335,924 | The ETF sold 2740 shares of GILD on 2026-01-12. The shares were previously bought for an average price of USD 112.37. The Guild Esports Plc shares were sold for 9.1% higher than average price of previous purchases. This sale made a profit of USD 28,030 The average price that the ETF previously sold GILD share for is USD 101.331 so the ETF has sold 2740 shares on 2026-01-12 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -1,188 @ USD 325.54 | USD -386,742 | The ETF sold 1188 shares of AMGN on 2026-01-12. The shares were previously bought for an average price of USD 305.63. The Amgen Inc shares were sold for 6.5% higher than average price of previous purchases. This sale made a profit of USD 23,653 The average price that the ETF previously sold AMGN share for is USD 293.145 so the ETF has sold 1188 shares on 2026-01-12 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -784 @ USD 572.745 | USD -449,032 | The ETF sold 784 shares of ISRG on 2026-01-12. The shares were previously bought for an average price of USD 522.86. The Intuitive Surgical Inc shares were sold for 9.5% higher than average price of previous purchases. This sale made a profit of USD 39,110 The average price that the ETF previously sold ISRG share for is USD 532.012 so the ETF has sold 784 shares on 2026-01-12 at a higher price than the previous selling average. |
| ABT - Abbott Laboratories | SELL | -3,840 @ USD 124.64 | USD -478,618 | The ETF sold 3840 shares of ABT on 2026-01-12. The shares were previously bought for an average price of USD 128.535. The Abbott Laboratories shares were sold for -3.0% lower than average price of previous purchases. This resulted in an overall loss of USD 14,957 The average price that the ETF previously sold ABT share for is USD 122.199 so the ETF has sold 3840 shares on 2026-01-12 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -828 @ USD 615.45 | USD -509,593 | The ETF sold 828 shares of TMO on 2026-01-12. The shares were previously bought for an average price of USD 523.995. The Time Out Group plc shares were sold for 17.5% higher than average price of previous purchases. This sale made a profit of USD 75,725 The average price that the ETF previously sold TMO share for is USD 505.635 so the ETF has sold 828 shares on 2026-01-12 at a higher price than the previous selling average. |
| MRK - Marks Electrical Group PLC | SELL | -5,488 @ USD 109.19 | USD -599,235 | The ETF sold 5488 shares of MRK on 2026-01-12. The shares were previously bought for an average price of USD 90.678. The Marks Electrical Group PLC shares were sold for 20.4% higher than average price of previous purchases. This sale made a profit of USD 101,594 The average price that the ETF previously sold MRK share for is USD 94.299 so the ETF has sold 5488 shares on 2026-01-12 at a higher price than the previous selling average. |
| MRK - Merck & Company Inc | SELL | -5,488 @ USD 109.19 | USD -599,235 | The ETF sold 5488 shares of MRK on 2026-01-12. The shares were previously bought for an average price of USD 90.678. The Merck & Company Inc shares were sold for 20.4% higher than average price of previous purchases. This sale made a profit of USD 101,594 The average price that the ETF previously sold MRK share for is USD 94.299 so the ETF has sold 5488 shares on 2026-01-12 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -2,000 @ USD 340.51 | USD -681,020 | The ETF sold 2000 shares of UNH on 2026-01-12. The shares were previously bought for an average price of USD 403.204. The UnitedHealth Group Incorporated shares were sold for -15.5% lower than average price of previous purchases. This resulted in an overall loss of USD 125,388 The average price that the ETF previously sold UNH share for is USD 473.234 which is higher than the selling price of USD 340.51 on 2026-01-12. |
| ABBV - AbbVie Inc | SELL | -3,900 @ USD 220.04 | USD -858,156 | The ETF sold 3900 shares of ABBV on 2026-01-12. The shares were previously bought for an average price of USD 208.008. The AbbVie Inc shares were sold for 5.8% higher than average price of previous purchases. This sale made a profit of USD 46,925 The average price that the ETF previously sold ABBV share for is USD 191.791 so the ETF has sold 3900 shares on 2026-01-12 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -5,320 @ USD 209.72 | USD -1,115,710 | The ETF sold 5320 shares of JNJ on 2026-01-12. The shares were previously bought for an average price of USD 176.673. The Johnson & Johnson shares were sold for 18.7% higher than average price of previous purchases. This sale made a profit of USD 175,810 The average price that the ETF previously sold JNJ share for is USD 159.654 so the ETF has sold 5320 shares on 2026-01-12 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -1,752 @ USD 1081 | USD -1,893,912 | The ETF sold 1752 shares of LLY on 2026-01-12. The shares were previously bought for an average price of USD 859.069. The Eli Lilly and Company shares were sold for 25.8% higher than average price of previous purchases. This sale made a profit of USD 388,823 The average price that the ETF previously sold LLY share for is USD 815.672 so the ETF has sold 1752 shares on 2026-01-12 at a higher price than the previous selling average. |